U.S. Diversified Financial Stock News

In July 2026, Stifel Financial Corp. reported second-quarter revenue of US$1,638.78 million and net income of US$226.48 million, with basic earnings per share from continuing operations rising to US$1.41 from US$0.94 a year earlier. Alongside this stronger profitability, Stifel continued to return capital to shareholders, repurchasing 2,419,000 shares for US$177.04 million in the quarter under its long-running buyback program. We’ll now examine how this jump in quarterly earnings per share...

Investors in Xylem Inc. ( NYSE:XYL ) had a good week, as its shares rose 5.2% to close at US$122 following the release...

Investors were underwhelmed by the solid earnings posted by The Vita Coco Company, Inc. ( NASDAQ:COCO ) recently. We...

The market hit Titan America hard. The stock closed down about 9% on the day, even though the headline story was not revenue cracking but margins compressing. Q2 revenue came in at about US$470.6m while net income landed near US$43.3m. The emotional trigger was the squeeze in profitability as adjusted EBITDA margin stepped down and earnings per share slipped versus last year. For you as an investor, the real question is whether this margin pressure is a one quarter supply and logistics...

Workiva (NYSE:WK) has introduced three specialized AI agents for reporting and compliance workflows. The company also launched Workiva Knowledge, a persistent intelligence layer that supports finance, sustainability, and risk teams. The new tools are designed to automate complex tasks, support traceability, and help customers address evolving regulatory requirements. Workiva operates a cloud platform that connects reporting, compliance, and risk activities across finance and sustainability...

NOV walked into this earnings print with a mixed scorecard and a stock that had edged higher over the past month. However, the first trading day after the release saw the share price slip about 4% to roughly US$19.06. That drop sits against a quarter where NOV produced Q2 2026 revenue of about US$2.13b and net income of US$112m, with adjusted EBITDA margins in the low teens. The real story for investors is the tension between that margin picture and the stock’s still rich 72x trailing P/E...

Regeneron Pharmaceuticals has delivered a 28.2% return over the past year, yet its valuation checks still lean toward the stock looking inexpensive rather than stretched. That sits against a backdrop of mixed sentiment, with recent legal action around a failed melanoma trial raising questions about how much risk is already reflected in the current share price. Regeneron Pharmaceuticals is up 28.2% over the past year, which puts recent shareholders in profit and is prompting closer scrutiny...

US dollar beneficiaries are back in focus as investors weigh stubborn inflation signals, a 5.23% US 30-year Treasury yield, and higher oil prices linked to conflict in Iran and shipping risks in the Strait of Hormuz. When borrowing costs jump and policy signals feel uncertain, exporters and multinationals with meaningful foreign earnings can behave very differently from purely domestic stocks. This article walks through 3 stocks from a US Dollar Beneficiaries screener that appear positively...

Some Karooooo Ltd. ( NASDAQ:KARO ) shareholders may be a little concerned to see that the Founder, Isaias Jose Calisto...

We wouldn't blame Essential Properties Realty Trust, Inc. ( NYSE:EPRT ) shareholders if they were a little worried...

The recent 10% drop in Eightco Holdings Inc.'s ( NASDAQ:ORBS ) stock could come as a blow to insiders who purchased...

Anyone interested in Bitgo Holdings, Inc. ( NYSE:BTGO ) should probably be aware that the Co-Founder, Michael Belshe...

It's been a pretty great week for Neptune Insurance Holdings Inc. ( NYSE:NP ) shareholders, with its shares surging 17...

Appian stock has rebounded in the short term, yet both the Discounted Cash Flow (DCF) intrinsic value estimate and the broader valuation checks still point to shares trading below what the underlying cash flows suggest. Appian shareholders have seen the stock fall 73.8% over the past 5 years, which puts recent gains into the context of a long period of weak returns. The investment case may hinge on whether Appian can convert its software platform into stronger, more predictable cash flows,...

Roper Technologies recently reported past second-quarter 2026 results showing sales of US$2,108.9 million and net income of US$1.17 billion, alongside a completed buyback of 8,995,000 shares for US$3.20 billion under its October 2025 authorization. The sharp uplift in quarterly earnings per share from continuing operations, combined with sizeable share repurchases, highlights how operational performance and capital allocation are working together to reshape Roper’s financial profile. We’ll...

Those following along with Albertsons Companies, Inc. ( NYSE:ACI ) will no doubt be intrigued by the recent purchase of...

Concrete Pumping Holdings, Inc. ( NASDAQ:BBCP ), is not the largest company out there, but it saw a significant share...

Qualcomm (NasdaqGS:QCOM) has completed its acquisition of Modular Inc, an AI native software infrastructure company. The company has also entered a long term semiconductor supply agreement with BMW Group for next generation AI powered vehicle platforms. Both developments expand Qualcomm's role in AI centric computing and automotive technology beyond its core mobile business. These moves place Qualcomm more firmly at the center of two large themes investors are watching closely: AI compute...

Freshpet stock sits at an interesting crossroad today. The Discounted Cash Flow (DCF) intrinsic value estimate points to a sizeable gap to the upside, while market based valuation multiples lean the other way and suggest the shares are on the expensive side. Over the past 5 years, Freshpet shares have declined 55.5%, which places the current valuation debate against a backdrop of weak long term returns. For a company like Freshpet, expectations for sustained revenue growth and progress...

United States Lime & Minerals has delivered very strong long term share price gains over the past 5 years, yet its low value score and mixed valuation signals suggest the stock may no longer be an obvious bargain at around US$113 per share. The stock has returned about 298% over 5 years, which puts extra focus on whether that past performance is already priced into today’s valuation. Rising demand from construction and steel customers and the planned ramp up of a new kiln may support future...

Incyte received European Commission approval for Opzelura (ruxolitinib) cream to treat moderate atopic dermatitis in adults. This is Opzelura's second indication in Europe following its earlier approval for non segmental vitiligo. The decision expands Incyte's dermatology footprint in Europe and adds a new potential use case for Opzelura. For investors tracking Incyte, ticker NasdaqGS:INCY, the European approval for Opzelura comes as the stock trades at $127.1. The company has posted...

For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...

Over the last 7 days, the United States market has experienced a 2.6% decline, yet it remains up by 14% over the past year, with earnings anticipated to grow by 17% annually in the coming years. In this dynamic environment, identifying small-cap stocks with insider activity can provide valuable insights into potential opportunities for investors seeking to navigate these market conditions effectively.

Alcoa earnings and updated 2026 operating guidance Alcoa (AA) reported second quarter 2026 results with sales of US$3,966 million and net income of US$407 million, alongside updated operating guidance that reduced alumina production and shipment projections for the year. See our latest analysis for Alcoa. Despite the stronger second quarter, Alcoa’s recent guidance cut on alumina output has coincided with pressure on the stock, with the share price down 19.81% over 30 days and 24.16% year to...